We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

330 hedge funds and large institutions have $5.87B invested in Bio-Rad Laboratories Class A in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 102 increasing their positions, 132 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $20.4M | Put options by funds: $4.84M

10% more funds holding in top 10

Funds holding in top 10: 10 → 11 (+1)

2.38% less ownership

Funds ownership: 78.3% → 75.92% (-2.4%)

5% less funds holding

Funds holding: 347 → 330 (-17)

23% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 132

28% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 53

38% less capital inflows, than outflows

Capital inflows: $348M | Capital outflows: $566M

Holders
330
Holders Change
-17
Holders Change %
-4.9%
% of All Funds
7.13%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.24%
New
38
Increased
102
Reduced
132
Closed
53
Calls
$20.4​M
Puts
$4.84​M
Net Calls
+$15.5​M
Net Calls Change
+$18.9​M

BIO Hedge Fund Activity: Q2 2019 in Review

330 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2019, worth a combined $5.87B — down 1.4% from $5.95B a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of BIO and 38 opened new positions — a net loss of 15 holders — while 132 trimmed existing stakes and 102 added.

The largest buyer was Point72 Asset Management, adding an estimated $44.2M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $157M sold.

  • 330 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2019, down from 347 in Q1 2019.
  • Funds reported $5.87B of Bio-Rad Laboratories Class A stock for Q2 2019, down 1.4% quarter-over-quarter.
  • 38 funds opened new Bio-Rad Laboratories Class A positions in Q2 2019 and 53 closed out, a net change of -15 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2019 was Point72 Asset Management, an estimated $44.2M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2019 was Acadian Asset Management, an estimated $157M sold.

Based on aggregated 13F filings for Q2 2019.